Approval for adding quantitative determination of total antibodies to hepatitis b surface antigen in human adult, adolescent, and pediatric serum or plasma to the intended use. The device, as modified, will be marketed under the trade name advia® centaur anti-hbs(ahbs) assay on centaur cp and is indicated for:advia® centaur anti-hbs (ahbs) assay on the centaur cp analyzer:the advia centaur anti-hbs assay is an in vitro diagnostic immunoassay for the qualitative and quantitative determination of total antibodies to hepatitis b surfaceantigen in human adult, adolescent, and pediatric serum or plasma (edta or heparinized) using the advia centaur cp system. The assay results may be used as an aid in thedetermination of susceptibility to hepatitis b virus (hbv) infection in individuals prior toor following hbv vaccination or where vaccination status is unknown. Assay results maybe used with other hbv serological markers for the laboratory diagnosis of hbv diseaseassociated with hbv infection. A reactive assay result will allow a differential diagnosis in individuals displaying signs and symptoms of hepatitis in whom etiology is unknown.
Device | ADVIA CENTAUR ANTI-HBS (AHBS) |
Classification Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
Applicant | SIEMENS HEALTHCARE DIAGNOSTICS |
Date Received | 2009-09-28 |
Decision Date | 2010-09-01 |
PMA | P030029 |
Supplement | S009 |
Product Code | LOM |
Advisory Committee | Microbiology |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P030029 | | Original Filing |
S013 |
2012-03-26 |
Normal 180 Day Track No User Fee |
S012 |
2011-02-16 |
30-day Notice |
S011 |
2010-09-29 |
30-day Notice |
S010 | | |
S009 |
2009-09-28 |
Normal 180 Day Track |
S008 |
2009-08-21 |
30-day Notice |
S007 |
2009-05-18 |
Normal 180 Day Track |
S006 |
2009-03-31 |
Normal 180 Day Track |
S005 |
2009-03-03 |
Normal 180 Day Track No User Fee |
S004 |
2008-09-18 |
Normal 180 Day Track |
S003 |
2008-08-11 |
Normal 180 Day Track |
S002 | | |
S001 |
2007-03-14 |
135 Review Track For 30-day Notice |
NIH GUDID Devices